Clorazepate Dipotassium

氯卓酸二钾

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameClorazepate Dipotassium
Drug Alias Name二钾氯氮氯氮酸二钾盐安定羧酸钾盐二钾氯氮卓片氯草酸钾 +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersAlcoholismEpilepsy
Global Approved IndicationsAnxiety DisordersAlcoholismEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1972/06/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRecordati
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAnxiety DisordersAlcoholismEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN05BA05
Related LinksWikipediaDrugBankKEGG